John P. Roberts, MD, FACS

Stanford University, Palo Alto, CA, BS, 1976, Biology
University of California, San Diego, CA, MD, 1980, Medicine
University of Washington, Seattle, Surgery Resident, 1980-83
Cornell University, New York, Research Fellow, 1983-85
University of Washington, Seattle, Surgery Resident, 1985-86
University of Minnesota, Minneapolis, Transplant Fellow, 1986-87

• 1988-1993
  University of California San Francisco, Assistant Professor
• 1993-1997
  University of California San Francisco, Associate Professor
• 1995-present
  California Pacific Medical Center, San Francisco, Surgical Director, Liver Transplant Department
• 1997-present
  University of California San Francisco, Professor
• 1999-present
  University of California San Francisco, Chief, Transplant Service

• 1991
  Chief Resident Teaching Award, Department of Surgery, UCSF
• 1992
  Chief Resident Teaching Award, Department of Surgery, UCSF

• Yao,FY; Ferrell,L; Bass, NM; Watson, JJ; Bacchetti, P; Venook, A; Ascher,NL; Roberts, JP. Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival. Hepatology, 2001; 33(6): 1394-1403.
• Mahanty, HD; Cherikh, WS; Chang, GJ; Baxter-Lowe, LA; Roberts, JP. Influence of Pretransplant Pregnancy on Survival of Renal Allografts from Living Donors. Transplantation, 2001; 72(2): 228-32.
• Yao F, Bass NM, Watson J, Davern T, Wu V, Moore B, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma - Analysis of survival according to Intention-to-Treat, and the rate of "drop-out" from the waiting list. Hepatology, 2001; 34:174A.
• Kashef, E; Roberts, JP. Transplantation for Hepatocellular Carcinoma. Seminars in Oncology, 2001; 28(5): 497- 502.
• Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transplantation, 2002; 8(9):765-74.
• Roberts, JP. Prioritization of Patients With Liver Cancer Within the MELD System. Liver Transplantation, 2002; 8(4): 329-30.
• Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. A Follow-up Analysis of the Pattern and Predictors of Dropout From the Waiting List for Liver Transplantation in Patients with Hepatocellular Carcinoma: Implications For the Current Organ Allocation Policy. Liver Transplantation, 2003; 9(7):684-92.
• Chang GJ, Mahanty HD, Ascher NL, Roberts JP. Expanding the donor pool: can the Spanish model work in the United States? American Journal of Transplantation, 2003; 3(10): 1259-63.
• Roberts JP, Nikolai B, Tomlanovich SJ. Cost of organ procurement and transplantation network data collection for a transplant center. American Journal of Transplantation, 2003; 3(10): 1316-7.
• Roberts JP. Role of adult living liver donation in patients with hepatocellular cancer. Liver Transplantation, Review. No abstract available, 2003; (10 Suppl 2): S60-3.
• Hebert MF, Wacher VJ, Roberts JP, Benet LZ. Pharmacokinetics of cyclosporine pre- and post-liver transplantation. Journal of Clinical Pharmacology, 2003; 43(1): 38-42.
• Yao FY, Saab S, Bass NM , Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Prediction of Survival after Liver Retransplantation for Late Graft Failure Based on Preoperative Prognostic Scores. Hepatology, 2004; 39: 230-38.
• Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK. Influence of graft type on outcomes after pediatric liver transplantation. American Journal of Transplantation, 2004; 4(3):373-7.
• Roberts JP, Wolfe RA, Bragg-Gresham JL, Rush SH, Wynn JJ, Distant DA, Ashby VB, Held PJ, Port FK. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. New England Journal of Medicine, 2004; 350(6):545-51.